Spectrum of mast cell activation disorders

CD203c is Overexpressed on Neoplastic Mast Cells in Systemic Mastocytosis and is Upregulated upon IgE Receptor Cross-Linking

(2017) A.W. Hauswirth et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

A Case Series of a Luteolin Formulation (Neuroprotek®) in Children with Autism Spectrum Disorders

(2017) T.C. Theoharides et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

The “missing link” in autoimmunity and autism: Extracellular mitochondrial components secreted from activated live mast cells

(2013) Theoharis C. Theoharides et al.   AUTOIMMUNITY REVIEWS

Atopic Conditions in Search of Pathogenesis and Therapy

(2013) Theoharis C. Theoharides   CLINICAL THERAPEUTICS

Expanding Spectrum of Mast Cell Activation Disorders: Monoclonal and Idiopathic Mast Cell Activation Syndromes

(2013) Matthieu Picard et al.   CLINICAL THERAPEUTICS

An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders

(2013) Anilia Taliou et al.   CLINICAL THERAPEUTICS

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM

(2013) Iván Álvarez-Twose et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Familial Occurrence of Systemic Mast Cell Activation Disease

(2013) Gerhard J. Molderings et al.   PLoS One

Do mast cells link obesity and asthma?

(2012) N. Sismanopoulos et al.   ALLERGY

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

(2012) I. Alvarez-Twose et al.   ALLERGY

Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components

(2012) Sa A. Wang et al.   AMERICAN JOURNAL OF HEMATOLOGY

Immunology and Clinical Manifestations of Non-Clonal Mast Cell Activation Syndrome

(2012) Juan-Carlos Cardet et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Mast Cells in Allergic and Inflammatory Diseases

(2012) Nikolaos Sismanopoulos et al.   CURRENT PHARMACEUTICAL DESIGN

Mitochondria Distinguish Granule-Stored from de novo Synthesized Tumor Necrosis Factor Secretion in Human Mast Cells

(2012) Bodi Zhang et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Evaluation of Mast Cell Activation Syndromes: Impact of Pathology and Immunohistology

(2012) H.-P. Horny et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin

(2012) Shahrzad Asadi et al.   Journal of Neuroinflammation

Evidence questioning cromolyn’s effectiveness and selectivity as a ‘mast cell stabilizer’ in mice

(2012) Tatsuya Oka et al.   LABORATORY INVESTIGATION

Stimulated Human Mast Cells Secrete Mitochondrial Components That Have Autocrine and Paracrine Inflammatory Actions

(2012) Bodi Zhang et al.   PLoS One

Diagnosis and Treatment of Cutaneous Mastocytosis in Children

(2011) Mariana Castells et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Omalizumab Treatment of Systemic Mast Cell Activation Disease: Experiences from Four Cases

(2011) Gerhard J. Molderings et al.   INTERNAL MEDICINE

Clinical and Laboratory Parameters of Mast Cell Activation as Basis for the Formulation of Diagnostic Criteria

(2011) Peter Valent et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

(2011) Peter Valent et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms

(2011) I. Alvarez-Twose et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Human mast cell degranulation and preformed TNF secretion require mitochondrial translocation to exocytosis sites: Relevance to atopic dermatitis

(2011) Bodi Zhang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations

(2011) Matthew J. Hamilton et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mast cells squeeze the heart and stretch the gird: Their role in atherosclerosis and obesity

(2011) Theoharis C. Theoharides et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Mast cells and inflammation

(2010) Theoharis C. Theoharides et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients

(2010) Ignacio Blanco et al.   CLINICAL RHEUMATOLOGY

Mastocytosis and insect venom allergy

(2010) Patrizia Bonadonna et al.   Current Opinion in Allergy and Clinical Immunology

The diagnosis and management of anaphylaxis practice parameter: 2010 Update

(2010) Phillip Lieberman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mast cell activation syndrome: Proposed diagnostic criteria

(2010) Cem Akin et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype

(2010) Konstantin Dirscherl et al.   Journal of Neuroinflammation

Luteolin Inhibits Microglia and Alters Hippocampal-Dependent Spatial Working Memory in Aged Mice

(2010) Saebyeol Jang et al.   JOURNAL OF NUTRITION

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

(2010) T. C. Theoharides et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

(2010) S.-W. Jang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A simple 3-day “rush” venom immunotherapy protocol: documentation of safety

(2009) D. Kalogeromitros et al.   ALLERGOLOGIA ET IMMUNOPATHOLOGIA

Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy

(2009) M. Niedoszytko et al.   ALLERGY

Topical sodium cromoglicate relieves allergen- and histamine-induced dermal pruritus

(2009) R. Vieira dos Santos et al.   BRITISH JOURNAL OF DERMATOLOGY

Dose- and time-dependent effects of luteolin on carbon tetrachloride-induced hepatotoxicity in mice

(2009) Robert Domitrović et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Rupatadine Inhibits Proinflammatory Mediator Secretion from Human Mast Cells Triggered by Different Stimuli

(2009) Magdalini Vasiadi et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Assessing anaphylactic risk? Consider mast cell clonality

(2009) Dean D. Metcalfe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

(2009) Patrizia Bonadonna et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells

(2008) D Kempuraj et al.   BRITISH JOURNAL OF PHARMACOLOGY

Urticaria pigmentosa associated with acute stress and lesional skin mast-cell expression of CRF-R1

(2008) T. C. Theoharides et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Prevention of Mast Cell Activation Disorder-Associated Clinical Sequelae of Excessive Prostaglandin D2 Production

(2008) Joseph H. Butterfield et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation

(2008) Han-Qing Chen et al.   NEUROSCIENCE LETTERS